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running head: Characterization of cardiac microtissues 
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Abstract 
 
Purpose: Cardiomyocytes are terminally differentiated cells in the adult heart and 
ischemia and cardiotoxic compounds can lead to cell death and irreversible decline 
of cardiac function. As testing platforms, isolated organs and primary cells from 
rodents have been the standard in research and toxicology, but there is a need for 
better models that more faithfully recapitulate native human biology. Hence, a new in 
vitro model comprising the advantages of 3D cell culture and the availability of 
induced pluripotent stem cells (iPSC) from human origin was developed and 
characterized. 
Methods: Human cardiomyocytes (CMs) derived from induced pluripotent stem cells 
(iPSCs) were studied in standard 2D culture and as cardiac microtissues (MTs) 
formed in hanging drops.  2D cultures were examined using immunofluorescence 
microscopy and Western blotting while the cardiac MTs were subjected to 
immunofluorescence, contractility, and pharmacological investigations. 
Results: iPSC-derived CMs in 2D culture showed well-formed myofibrils, cell-cell 
contacts positive for connexin-43, and other typical cardiac proteins.  The cells 
reacted to pro-hypertrophic growth factors with a substantial increase in myofibrils 
and sarcomeric proteins. In hanging drop cultures, iPSC-derived cardiomyocytes 
formed spheroidal MTs within 4 days showing a homogeneous tissue structure with 
well-developed myofibrils extending throughout the whole spheroid without a necrotic 
core. MTs showed spontaneous contractions for more than 4 weeks that were 
recorded by optical motion tracking, sensitive to temperature, and responsive to 
electrical pacing. Contractile pharmacology was tested with several agents known to 
modulate cardiac rate and viability. Calcium-transients underlay the contractile 
activity and were also responsive to electrical stimulation, caffeine-induced Ca2+-
release, extracellular calcium levels. 
Conclusions: 3D culture using iPSC-derived human cardiomyocytes provides an 
organoid human-based cellular platform that is free of necrosis and recapitulates vital 
cardiac functionality, thereby providing new and promising relevant model for the 
evaluation and development of new therapies and detection of cardiotoxicity. 
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Introduction 
 
Traditional cell culture in flat, rigid polystyrene dishes or similar culture formats, 
where the cells grow in a monolayer, has served its purpose well for many years and 
will continue to do so for certain applications in future. Nevertheless, it became 
evident during the past decade that this system is limited when it comes to reliably 
predicting efficacy and safety of new drugs. One third of all drug withdrawal from 
1990 to 2006 has occurred for direct cardiotoxicity (1) indicating that commonly used 
model systems lack the predictive power for early and accurate detection of this type 
of toxicity. The majority of drug attrition occurs in late stages of development when 
the costs incurred are already very high (2). Therefore, there is a clear need for in 
vitro models that faithfully replicate the tissue environment. For the heart this means 
consideration of dynamic factors such as motion and stretch, electrical 
communication and paracrine stimuli from neighboring cells within the tissue. 
Furthermore, the cells should be from human origin in order to take into account 
species-specific gene expression, signaling mechanisms, electrophysiological 
properties and for testing antibody therapies. 
New concepts have to be developed to create cardiac models systems to be used for 
cardiotoxicity testing, ideally in a standard multi-well format, which would also allow 
medium to high throughput screening. 3D-culture is a new alternative to the classical 
approaches and can help bridge the gap between 2D-culture and tissue (3,4). At 
present, 3D culture systems exist in many variants for different tissue types and 
applications. Nevertheless, 3D-culture is not yet widely used in cardiovascular 
research and toxicology. Gravity-enforced assembly of microtissues was found to be 
applicable to a variety of cell types for use in toxicology and drug development(5-7), 
Therefore, we have adapted self-assembling, scaffold-free, spheroidal microtissue 
aggregation in hanging drop techniques as the platform of choice in this study. This 
study also utilizes iPSC-derived human cardiomyocytes, which can be differentiated 
at industrial scale and quality from both healthy and patient populations, thus 
providing a substrate for both efficacy and safety studies. These cells have been 
used in a number of projects so far and their electrophysiological, genetic and 
toxicological properties have been characterized(8-12). Hanging drop microtissues of 
iPSC-CMs can be produced in a consistent manner, do not require the addition of 
extracellular matrix proteins, and overcome the sourcing, handling, and phenotypic 
hurdles associated with primary human cardiomyocytes. Here we demonstrate that 
scaffold-free 3D culture of commercially available iPSC-derived cardiomyocytes is 
feasible and results in reproducible microtissues that reliably respond to external 
electrical, pharmacological and physical stimuli and show long-term viability. 
Morphological and functional characterization emphasizes that this model may 
become a valuable tool for substance safety testing in the future. 
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Material and Methods 
 
Culture of induced pluripotent stem cell (iPSC)-derived cardiomyocytes in standard 
culture 
 
Human iPSC-derived human cardiomyocytes (iCell® Cardiomyocytes) were obtained 
from Cellular Dynamics International Inc. (CDI, Madison, WI, USA). Nascent CMs are 
allowed to mature until day 32 at which point they are frozen for shipping. The details 
of the procedure were published previously (21). For standard 2D culture, 
cryopreserved cardiomyocytes were rapidly thawed, then diluted in iCell Plating 
Medium (iCPM, CDI) and seeded into culture dishes (Nunc) coated with 0.1% gelatin 
in water. After 48 hours, medium was changed to iCell Maintenance Medium (iCMM, 
CDI) and then changed every three days. 1% penicillin–streptomycin (Gibco, 
Invitrogen) was added to all culture media. In a specific set of experiments, DMEM 
with Glutamax (Gibco, Invitrogen) with the addition of 20% fetal calf serum (PAA 
Laboratories) and recombinant human insulin-like growth factor-I (IGF-I) (Sigma) at 
500 ng/ml was used.  
 
3D microtissue culture and viability testing 
 
Cryopreserved cardiomyocytes were diluted in iCPM and directly seeded in hanging 
droplets in a volume of 40 µl medium per droplet using the GravityPlusTM system 
(InSphero). The starting number of viable cardiomyocytes was at least 2500, or as 
indicated in the results section, and adjusted according to the reported viability 
parameter of the production lot. After 4 days in the hanging drop without medium 
change, the spheroids were transferred to a 96-well microtissue receiver plate with 
non-adhesive surface (GravityTRAPTM, InSphero) in a volume of 70 µl iCMM per 
well. In some experiments, the alpha 1 adrenergic agonist phenylephrine was added 
in the final concentration of 100 µM and combined with 30 µM ascorbic acid (Sigma). 
Spontaneous beating rate over the entire culture period was assessed by manually 
counting contraction rate using an inverted microscope for 30 seconds once every 2 
days before medium exchange. For this assessment, the GravityPlusTM plate was 
regularly returned to the incubator in order to keep the temperature constant. The 
Live/Dead assay consisting of the fluorescent dyes calcein-AM and ethidium 
homidimer-1 (Biotium) was used to determine viability of 2D- and 3D-cultured 
cardiomyocytes. 
 
High-resolution calcium imaging 
 
MTs were allowed to attach to laminin-coated glass bottom dishes (MatTek, Ashland 
MA, USA) overnight and then loaded with fluo-4-AM purchased from Life 
Technologies dissolved in DMSO (30 min at room temperature, de-esterification for 
10 min). Images were obtained using a laser-scanning confocal microscope 
(MicroRadiance, BioRad; Nikon TE300 Eclipse) using 40x oil and 63x water-
immersion objectives. The fluorescent probe was excited with a laser line at 488 nm, 
emission was collected above 510 nm. Line-scan images were recorded at a rate of 
50 lines/s. Changes in fluorescence are shown as ΔF/F0. External bath solution 
contained (in mM):  140 NaCl, 5.4 KCl, 1.1 MgCl2, 1.8 CaCl2, 5 HEPES, 10 Glucose 
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(pH 7.4). For rapid solution exchange for the modulation of extracellular calcium 
(from 1.8 to 0.5 mM Ca2+) and caffeine-treatment (10 mM), a custom-built buffer 
switching system was used. All experiments were performed at room temperature.  
 
Assessment of microtissue contractions and pharmacologic treatments 
 
MTs were transferred from GravityTrapTM culture to glass-bottom dishes (MatTek) for 
attachment. Medium for these cultures contained 25 mM HEPES (Sigma) in order to 
maintain pH. Culture dishes were placed on a heated platform on a Nikon Eclipse 
TE2000-U inverted microscope and bath temperature was measured with a wire 
sensor and temperature controller (Warner Instrument Corp.). Microtissue motion 
was recorded at a video frequency of 240 Hz (MyoCam, IonOptix,) using the 
SoftEdge detection method and processed with IonWizard analysis software 
(IonOptix). Different pharmacological agents were tested on spontaneously 
contracting MTs at 37°C by solving the respective chemical in medium and replacing 
the culture medium in the glass bottom-dish before video analysis. 
 
Immunocytochemistry of 2D-cultured cells and whole-mount staining of MTs 
 
Cells cultured on gelatin-coated polystyrene culture dishes (Nunc) were washed with 
PBS then fixed with 3% para-formaldehyde in PBS for 15 min, permeabilized with 
0.2% Triton-X100 (Sigma) in PBS for 10 min, incubated for 30 min with bovine serum 
albumin (Sigma) 1 mg/mL in PBS at room temperature, incubated over night with 
primary antibodies at 4 °C, washed 3 times with PBS and incubated 1 h with 
secondary antibodies coupled to Alexa fluorescent dyes (Invitrogen). DAPI (Sigma) 
was added to visualize the nuclei. For whole-mount immunostaining of MTs, 
spheroids were allowed to adhere onto glass-bottom dishes (MatTek). After fixation 
with 3% para-formaldehyde for 1 h in the cold, permeabilization and antibody 
incubation steps in 1%BSA/PBS/10% Tween-20 (AppliChem) were prolonged to 1 
day each before examination by confocal microscopy. Preparations were examined 
on a Zeiss LSM 5 Exciter confocal microscope using 40x and 63x Zeiss oil immersion 
lenses (Carl Zeiss).  
 
Histology and immunolabeling of cryo- and paraffin sections 
 
Cryosections: at least 8 MTs per group were collected by gentle spinning in a 1.5-ml 
tube. The MTs were then fixed with 3% para-formaldehyde in PBS for 15 min, 
washed with PBS, stored in and embedded in OCT compound. Blocks were then cut 
using a Zeiss cryostat. Frozen sections (10 µm) on slides were air dried for at least 1 
hour. After a blocking step with 1%BSA/PBS, primary antibodies in 1%BSA/PBS and 
0.3% Tween20 were applied overnight. For classical histological staining 
(hematoxylin-fuchsin or mayers-haemalaun (Sigma)) of paraffin sections, MTs were 
harvested, fixed with 3% para-formaldehyde for 1 hour in PBS, collected in agarose 
plugs and processed as described previously(13). For immunohistochemical labeling 
of paraffin sections, MTs were harvested and fixed as described. Primary antibodies 
were detected with the Ventana iVIEW DAB detection kit, resulting in a brown 
reaction product. Sections were counterstained with hematoxylin and covered with a 
glass cover slip.  
 
Antibodies 
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To visualize myofibrils in cardiomyocytes, we used monoclonal antibodies to 
myomesin (clone B4, obtained from the Developmental Studies Hybridoma Bank, 
Univ. of Iowa) and polyclonal antibodies to human embryonic heart-specific 
myomesin(14). Additionally, polyclonal antibodies to connexin-43 (ab11370, Abcam), 
to all-actin (A2066, Sigma) and monoclonal antibodies to the cytoplasmic domain 
ED-A of fibronectin (sc-59826, St. Cruz Biotech) were used.  
 
Statistical analysis 
 
All values are expressed as mean ± S.D. Statistical analysis of differences observed 
between the groups was performed by Student’s unpaired t-tests. Statistical 
significance was accepted at the level of p < 0.05. 
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Results 
 
 
Characterization of iPSC-derived cardiomyocytes in 2D-culture 
 
 Cryopreserved iPSC-derived cardiomyocytes were thawed and cultured 
according to the manufacturer’s protocol using plating medium for the first 48 hours 
and maintenance medium during the rest of the culture time. After 4-5 days, a dense 
monolayer of spontaneously contracting cardiomyocytes had developed. After 10 
days in standard 2D-culture, cells were fixed and immunostained for sarcomeric and 
gap junction proteins (Fig. 1 A). The majority of cells showed well-formed myofibrils 
positive for the sarcomeric protein myomesin and actin-stress fibers. In another line 
of experiments, iPSC-derived cardiomyocytes were cultured all the time in 
hypertrophy-inducing media consisting of DMEM with the addition of 20%FCS and 
insulin-like growth factor 1 (IGF-I) at 500 ng/ml (Fig. 1 B). Under these conditions, the 
sarcomeric cytoskeleton appeared very prominent in the immunostained cells 
suggesting a hypertrophic response to this growth factor with enhanced expression 
of muscle proteins as has been described in cultures of primary neonatal and adult 
rat cardiomyocytes (15,16). Increased proliferation of non-muscle cells was also 
observed in this rich medium (not shown). Cells cultured in maintenance medium 
were fixed and immunostained for myomesin and for connexin-43 in order to label 
gap junctions at cell-cell contacts, which were found in the expected pattern (Fig. 1 
C). The embryonic heart-specific isoform of the sarcomeric M-line protein myomesin 
was found in all cells (Fig. 1 D). We performed Western blotting for the detection of 
several proteins that were described in cultures of primary cardiomyocytes isolated 
from rat or mouse (supplemental figure 1). Among them, cytoskeleton/sarcomeric 
proteins (beta myosin heavy chain, sarcomeric alpha actinin, alpha-smooth muscle 
actin, desmin, embryonic-heart myomesin, MLC2v, MLC2a), receptor tyrosine 
kinases (ErbB2, ErbB4, VEGFR2), proteins involved in Ca2+ handling (ryanodine 
receptor2, sodium-calcium exchanger, sarcoplasmic reticulum ATPase2a), and a 
heat shock protein (HSP70) were detected in the standard-cultured iPSC-derived 
cardiomyocytes. The detection of alpha-smooth muscle actin and embryonic heart 
specific myomesin isoform suggests that the cardiomyocytes may be under slightly 
stressed conditions, or indicates a fetal or neonatal pattern of gene expression in 
these cardiomyocytes, since they are not expressed in unstressed adult human 
myocardium (17). 
 
 
Characterization of microtissues made of iPSC-derived cardiomyocytes 
 
 Spheroid microtissues assembled in the hanging drop format (GravityPLUSTM) 
in plating medium for 4 days and were harvested and transferred into non-adhesive 
GravityTRAPTM assay plates with a conical well and a flat bottom with the diameter of 
1 mm containing maintenance medium (Fig. 2 A). MTs were fixed after 3 weeks with 
medium changes every 3 days and subjected to several methods of histology and 
immunocytochemistry such as paraffin embedding and histological staining of 
sections, immunolabeling of cryosections, whole-mount immunostaining and confocal 
microscopy of intact MTs (Fig. 2). Staining of paraffin sections from large MTs made 
of 10'000 cells with either hematoxylin-fuchsin or Mayers haemalaun demonstrated 
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the overall MT structure and distribution of nuclei (Fig. 2 B, C). General tissue 
staining of MTs showed an equal distribution of cells without a necrotic core, layering 
of different cell types or vacuolization. Occasionally, “pockets” of cellular debris in 
seemingly random location inside the MTs were observed (Fig. 2, C, asterisk). 
Immunohistochemistry for cleaved caspase-3 was done using paraffin sections of 
MTs at different time points (1 day after harvest from the hanging drops, 5 days and 
21 days) in culture. Only few positive cells were found inside MTs in a scattered 
distribution at all time points (supplemental fig. 2). Cryosections of MTs fixed and 
embedded in OCT were immunostained for myomesin, connexin-43 and stained with 
DAPI for the labeling of nuclei (Fig. 2 D1-D3). Cells showing sarcomeric striation 
were found over the entire area of the sections. Punctuated connexin-43 patterns 
indicating gap junctions were also detected on sections. The whole-mount 
preparation of MTs in combination with confocal microscopy allowed investigation of 
the distribution of proteins in the entire MT without physical sectioning. Good results 
could be obtained using our protocol with comparably small MTs of 2500 
cardiomyocytes allowing the attachment to glass bottom culture dishes for several 
days before fixation and with incubation with antibodies to human embryonic heart 
myomesin, cytoplasmic fibronectin, and DAPI (Fig. 2 E1-E3). Myofibrils in 
cardiomyocytes were found to be partially aligned with the curvature of the outer 
layer of the spheroid, and in this region myofibrils often continue linearly from one cell 
to the next (Fig. 2 E1). This intercellular structure corresponds to the typical picture of 
myofibril organization in a more mature myocardial tissue in vivo (18,19).  
Keeping the MT size constant within a series of experiments is a crucial requirement 
for any investigation using 3D cultures in order to obtain reproducible results. We 
have evaluated the relationship between the initial number of seeded cells and the 
resulting MT diameter as measured from photographs taken at day 10 in culture (Fig. 
3 A, B). The long-term spontaneous activity has not been characterized so far for 
iPSC-derived cardiomyocytes in scaffold-free 3D-culture. Generally, all MTs made of 
iPSC-derived cardiomyocytes showed spontaneous contractions directly after 
transfer into the GravityTRAPTM. MTs seeded with less than 2500 cells did not form 
any spheroid bodies but only loosely adherent clusters. We then assessed the rate of 
spontaneous contractions of MTs of different size over the course of 30 days in 
GravityTRAPTM culture every two days followed by medium exchange (Fig. 3 C 
above). It was observed that smaller MTs consisting of 2500 cells showed a 
consistently higher spontaneous contraction rate compared to larger MTs. In another 
experiment, the effect of phenylephrine, an alpha 1 adrenergic receptor agonist, on 
the spontaneous contraction rate of small MTs (2500 cells) (Fig. 3 C below) was 
evaluated. Addition of this compound increased and stabilized the spontaneous 
beating rate over culture time. We then evaluated cellular viability in the 3D culture 
after 5 days in culture and used the live/dead-assay (Fig. 3 D). A positive control for 
cardiotoxicity was provided by treating MTs with the broad-range tyrosine kinase 
inhibitor sunitinib malate at 0.1 µM over night. All untreated MTs showed an overall 
strong green fluorescent signal corresponding to live cells, but some necrotic cells 
were found in a scattered distribution in the red channel (Fig. 3 D). Those single 
necrotic cells might also explain the pockets of debris occasionally found by histology 
analysis (Fig. 3 C, asterisk). Necrotic cells were usually found directly after thawing of 
the cryopreserved cardiomyocytes (Fig. 3 D). On average we counted 6 times more 
calceine-AM positive cells than necrotic cells (not shown). We assume that necrotic 
cells originate from the initial pool of cryopreserved cells, which become incorporated 
into the microtissue. This assumption was corroborated by immunhistochemical 
staining for cleaved caspase-3 at three different time points in culture that showed a 
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scattered distribution of few positive cells inside MTs and no increase over culture 
time (supplemental fig. 2).  
 
 
Calcium handling in MT 
 
 Calcium handling is a fundamental element of excitation-contraction coupling 
(EC-coupling) in the single cardiomyocyte and disorders affecting the electro-
mechanical coupling are causal for the development of heart failure and life-
threatening arrhythmias. In toxicology, a model system of heart muscle needs to be 
able to properly react to known modulators of cardiac function. We therefore tested 
MTs made of iPSC-derived cardiomyocytes for cytosolic calcium signals and their 
response to external stimuli at high spatial and temporal resolution using fluo-4 as 
calcium-sensitive fluorescent probe (Fig. 4). The calcium indicator only partially 
penetrated into MTs as shown by optical sections comprising the surface and, in two 
different MTs, the center regions of the MTs (Fig. 4 A). The line-scans were obtained 
from single cells in the periphery of MTs. The spontaneous contractile activity of MTs, 
which can be recognized by a temporally highly synchronized global Ca2+ transient 
(Fig. 4 B), was occasionally proceeded by spontaneous and local Ca2+ release 
events in form of Ca2+ sparks or wavelets (Fig. 4 B). MTs were then subjected to 
electrical field stimulation. MTs responded to the external pacing and adapted to 
different stimulation frequencies, as shown in figure 4 C during the switch from 0.2 
Hz to 0.5 Hz. Using a rapid superfusion system, MTs were exposed to low Ca2+ 
concentrations, leading to interruption of the spontaneous Ca2+ release events and 
contractions, while addition of 10 mM caffeine, an agonist of the SR Ca2+ release 
channel ryanodine receptor, resulted in massive Ca2+ release from the sarcoplasmic 
reticulum (Fig. 4 D, E). Rapid decay of the Ca2+ transient and re-commencement of 
the spontaneous beating activity demonstrate functional Ca2+ removal mechanisms 
and efficient Ca2+ re-uptake into the SR, which is needed for the Ca2+ release for the 
next contraction. 
 
Measurement of spontaneous contractile activity by optical motion tracking 
 
 A video motion tracking system (IonOptix) was used to measure the contracti le 
activity of microtissues for several hours on an inverted microscope and using a 
heated stage platform equipped with a wire sensor for temperature measurements in 
the culture medium. A similar system has been used in our lab to record contractility 
of single isolated cardiomyocytes from the adult rat heart(20). The system follows the 
motion of any object showing high contrast (i.e. the unidirectional displacement of the 
edge of a microtissue) and displays the result as a line graph. Microtissues adherent 
on glass-bottom culture dishes were allowed to adapt to 37°C temperature and 
several recordings of 60 second duration were performed. Fig. 5 shows the 
spontaneous MT beating rate after adaptation to 37°C and examples of motion of the 
same MT after drug addition or temperature change at different time points. The 
general beta-adrenergic receptor agonist isoproterenol was used at 1 µM and led to 
an increase of spontaneous beating rate from 40 to 70 beats per minute (bpm) (Fig. 5 
A). Blebbistatin is a cell-permeable inhibitor for non-muscle myosin II ATPase and 
was used at a final concentration of 10 µM. This compound led to a decrease of the 
amplitude of MT motion and finally, the motion ceased 5 minutes after addition (Fig. 5 
B). Doxorubicin is a cancer chemotherapeutic drug with well-known cardiotoxic 
effects, which are related to the formation of reactive oxygen species, changes in 
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Ca2+ handling and mitochondrial function. The addition of 100 µM doxorubicin led to a 
change in the regularity of contractions as shown in a recording after 72 minutes (Fig. 
5 D). Besides the drug response, temperature-dependence of spontaneous MT 
activity was assessed in the range of 20°C up to 45°C (Fig. 5 E). MT contractions did 
not entirely stop at lower temperatures and showed a steep increase in frequency in 
the physiological range. Hyperthermic tachycardia was reversible upon return to 
normothermic conditions. 
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Discussion 
 
Neonatal rodent cardiomyocyte preparations are presently the most widely used cell 
type for the investigation of different cardiovascular research topics in vitro, since 
their isolation from tissue and maintenance is relatively easy compared to 
cardiomyocytes from adult animals or human tissue samples. Cardiomyocytes 
derived from hiPSC offer a constant supply of human cardiac cells without ethical 
concerns. These cells exhibit ionic currents and channel gating properties 
quantitatively similar to human cardiomyocytes (8,21) and express relevant cardiac 
marker proteins, and lack the expression of typical stem cell markers.  
3D culture models have rarely been used in cardiovascular research so far and many 
questions about their functional properties and biological relevance remain 
unresolved, which currently slows progress in the field. However, new advances in 
3D-culture have recently been stimulated by the needs of tissue engineering, stem 
cell research and the demand for better models in drug development. Adapted 
analysis methods and automation-compatible technologies make it easier now to 
implement these cultures in high throughput screening process (13,22). Microtissues 
in form of cellular spheroids take advantage of the inherent capability of many cell 
types to aggregate and can be obtained by the hanging-drop technique, non-
adhesive culture surfaces or by using rotating culture vessels. The first method has 
the advantage that MTs obtain the same size and shape when seeded with the same 
starting number of cells. Self-aggregating spheroids do not require a scaffold 
consisting of artificial materials or extracellular matrix proteins in form of matrigel. 
This is beneficial for several applications, since no animal-derived products with poor 
batch to batch reproducibility and the risk of disease transmission or potential 
interactions of screening compounds with the scaffold material have to be considered 
(23). On the other hand, not every cell type can be used to form spheroids by self-
aggregation and the resulting microtissue has to be checked for differentiation, 
functionality and viability. Scaffold-based cardiac constructs promote the linear 
alignment of cardiomyocytes and, by direct attachment to sensors, have been used 
to measure contractile force and other physiologic parameters (24). The hanging 
drop method for cell culture, as we have used here, is actually an older concept and 
even the use of cardiomyocytes to produce “mini hearts” dates back to the early 
seventies (25). A couple of pioneering studies of the last decade have provided 
technological innovations and a better understanding of this type of 3D culture and its 
potential for applications in tissue engineering and drug development (5,26,27). 
We have used non-proliferating, iPSC-derived cardiomyocytes for the generation of 
MTs and characterized their viability and specific cardiac features. The cells 
aggregated and formed 3D microtissues with defined size within 4 days in the 
hanging drop. Spontaneous contractile activity persisted for at least 1 month in 
GravityTrapTM culture with regular medium changes, and the addition of the alpha-
adrenergic receptor agonist phenylephrine enhanced and stabilized this activity. The 
internal structure of the MTs showed a homogenous tissue without central necrosis. 
Most cells assumed a spherical shape and were filled with myofibrils. Such a tissue 
structure is reminiscent of the fetal mammalian heart. Regional differentiation of 
strands of connected cells was observed in whole-mount preparations, and it remains 
to be investigated in detai l, if these groups of cells represent foci of contractile activity 
in the MTs. Pharmacological inhibition of myosin ATPase or stimulation of the beta-
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adrenergic system modulated cardiac functionality of the MTs in an expected 
manner.  
High-resolution calcium imaging using fluo-4 and confocal microscopy revealed 
spontaneous local Ca2+ release events and global Ca2+ transients, which could be 
modulated by electrical field stimulation, and a functional SR Ca2+ store as revealed 
by caffeine depletion. These results show that microtissues generate cardiac-like 
calcium transients, which in turn translate into contractions. The MTs rapidly 
responded to pharmacological and electrical stimuli, which suggests that the cells are 
adequately differentiated into the cardiogenic lineage. Hence, disturbances in these 
properties by cardiotoxic drugs would be effective in this system. Moreover, MT 
contractions could be enforced by electrical field pacing to reveal abnormalities in 
EC-coupling after exposure to different compounds. The fact that spontaneous 
contractile activity is strongly temperature dependent might be a challenge for a drug 
testing process that is not at least semi-automatic. Medium exchange and the 
addition of drugs outside of an incubator or warming chamber require temperature 
control and adaptation. Others have noted this issue with the same cell type in 2D 
culture (28).  
In conclusion, reproducible, scaffold-free 3D culture of iPSC-derived cardiomyocytes 
is feasible. Microtissues show long-term, stable functionality and respond to 
electrical, pharmacological and physical stimuli. This promising model warrants 
further study on the outcome of 3D culture conditions on cardiac toxicology and 
pathophysiology.  
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